James W. Stuckert - 12 Jun 2024 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Jun 2024, 17:46:20 UTC
Prior SEC filing
05 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James W. Stuckert

Key filing fact

James W. Stuckert filed Form 4 for Sanara MedTech Inc. (SMTI) on 14 Jun 2024.

Key facts

  • This page summarizes James W. Stuckert's Form 4 filing for Sanara MedTech Inc. (SMTI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Jun 2024, 17:46.

Change

  • Previous filing in this sequence was filed on 05 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Award

Transaction value
$0
Shares
+3,440
Change %
+0.41%
Price
$0.000000
Shares after
840,218
Date
12 Jun 2024
Ownership
Direct
Footnotes
F1
SMTI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
12 Jun 2024
Ownership
By Diane V. Stuckert Revocable Trust
SMTI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
46,500
Date
12 Jun 2024
Ownership
By James W. Stuckert Family Trust
SMTI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
70,254
Date
12 Jun 2024
Ownership
Ten Grand Ltd.
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date.

Footnote F2

The reporting person serves as the general partner of the partnership.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .